Patrícia Silva, PhD, director of science content —

Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.

Articles by Patrícia Silva

Why Nutrition Is So Important When You Have Cystic Fibrosis

Eating well is important for anyone who wants to stay healthy, but it’s especially true for those living with cystic fibrosis CF. If you suffer from CF, you have a deficiency in your pancreas. Due to multiple other symptoms, this deficiency causes you to produce fewer of the enzymes which help you digest food and absorb nutrients and fat, so you’ll feel the adverse effects when these enzymes are limited. This deficiency can manifest…

AIT Administers First Doses of Nitric Oxide in a Trial Testing Its Ability to Kill Drug-resistant Bacteria

AIT Therapeutics has administered its first doses of nitric oxide in a Phase 2 clinical trial of the compound’s ability to kill the drug-resistant bacteria often found in cystic fibrosis patients. The study’s overarching goal is to see whether AIT’s nitric oxide formulation can eliminate nontuberculous mycobacteria, or NTM, in patients…

Antabio Wins $2.8 Million Public-Private Partnership Grant to Keep Developing Drug-Resistant Infection Therapy

A U.S. government-backed initiative against drug-resistant bacteria has awarded Antabio $2.8 million to continue developing treatments for Pseudomonas, the most common infection in cystic fibrosis (CF). The grant came from a public-private partnership known as CARB-X, which stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator. CARB-X, formed in July 2016,…

4 Common Symptoms of Chest Infections

As cystic fibrosis (CF) primarily affects the lungs, cystic fibrosis patients are prone to chest infections. According to the Better Health Channel, a chest infection affects either the larger airways or the smaller air sacs of the lungs. Most chest infections are viruses, meaning that the body’s immune system…

Cystic Fibrosis Therapy Developer Novoclem Names Five Inaugural Members of Its Scientific Advisory Board

Novoclem Therapeutics, which is developing nitric oxide-releasing compounds that fight infections in cystic fibrosis and other respiratory diseases, has named five inaugural members of its scientific advisory board. They are Dr. Donald VanDevanter, adjunct professor at Case Western Reserve University School of Medicine; Dr. Felix Ratjen, a professor of pediatrics at the…

5 Lung Diseases That Affect the Airways

There is a broad spectrum of lung diseases, which is made up of any disease that causes the lungs to not function as they should. They affect different parts of the respiratory system, including the airways, lung tissue and blood circulation. Here are a few examples of lung diseases that affect millions of…